Anebulo Pharmaceuticals, Inc. ANEB
0.33
0.00
0.00%
as of 25 Sep
- Market cap
- $17.6M
- P/E
- 0.0×
Follow ANEB
Growth Flags
show if company had growth for consecutive years
| Jun '17 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | |
|---|---|---|---|---|---|---|---|
Current Ratio |
— | 13.53 | 89.63 | 30.40 | 10.92 | 13.46 | 24.53 |
Net Debt/EBITDA |
— | 17.45 | 5.53 | 2.13 | 0.95 | 0.38 | 1.32 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.86 | 0.13 | 0.80 | 0.83 | 0.99 | 0.75 |
Capex/Depreciation |
— | — | — | — | — | 0.00 | 0.00 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | (1.64%) | (362.14%) | (37.42%) | (91.41%) | (113.80%) | (109.69%) | |
| — | (11.53%) | (311.65%) | (36.66%) | (86.11%) | (104.19%) | (104.63%) | |
ROIC |
— | 0.00% | (158.37%) | (823.59%) | 0.00% | (722.96%) | (19,215.63%) |
Return on Tangible Assets |
— | (6.23%) | (179.62%) | (45.30%) | (110.67%) | (252.56%) | (73.94%) |
Average Days of Receivables |
— | 0.00 | — | — | — | — | 0.00 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | (0.01) | (0.36) | (0.23) | (0.39) | (0.31) | (0.19) |
Cash per Share |
— | 0.25 | 1.47 | 0.62 | 0.45 | 0.12 | 0.34 |
Shareholders Equity per Share |
— | (0.01) | 1.57 | 0.65 | 0.42 | 0.15 | 0.34 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (0.01) | 1.57 | 0.65 | 0.42 | 0.15 | 0.34 |
Free Cash Flow |
— | (0.15) | (4.87) | (5.44) | (9.68) | (8.09) | (6.35) |
Working Capital |
— | 2.80 | 21.41 | 15.07 | 10.60 | 3.25 | 11.47 |
Net Current Asset Value |
— | (0.17) | 21.41 | 15.07 | 10.60 | 3.25 | 11.47 |
| Other line items | |||||||
Quick Ratio |
— | 13.53 | 82.72 | 28.39 | 10.52 | 11.87 | 23.99 |
Depreciation/Fixed assets |
— | — | — | — | — | 0.00 | 0.00 |
Cash ROIC |
— | (5.28%) | (11.77%) | (18.36%) | (44.32%) | (117.14%) | (27.27%) |
Accounts Receivable Turnover |
— | — | — | — | — | — | 0.00 |
Accounts Payable Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (0.01) | (0.36) | (0.23) | (0.39) | (0.31) | (0.19) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | — | 0.04 |
Average Payables |
— | — | — | 0.25 | 0.46 | 0.35 | 0.19 |
Average Assets |
— | 1.51 | 12.34 | 18.62 | 13.62 | 7.87 | 8.11 |
Average Common Equity |
— | 10.62 | 10.62 | 18.24 | 12.83 | 7.21 | 7.74 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates